Jose Halperin, M.D. is a physician and researcher at Brigham and Women’s Hospital, where he serves as Director of the Laboratory for Translational Research in the Division of Hematology, and an Associate Professor of Medicine at Harvard Medical School. He is a pioneer in the understanding of the role of the complement system and the complement regulator CD59 in the pathogenesis of diabetes complications. Dr. Halperin holds over 40 awarded or filed patents, several of which have been licensed by Harvard University to companies working on bringing his inventions to the marketplace. Previously, Dr. Halperin founded and was a board member of Best Doctors, Inc. Dr. Halperin is also a founder and board member of Bioambar, SPA.
Dr. Halperin earned his M.D. degree from the University of Buenos Aires School of Medicine.
Links